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The aim of present study was to investigate the occurence of different lymphocyte
subsets in the endometrium of endometriosis patients and in healthy women on every
day of the menstrual cycle with special emphasis to the proliferative activity of
endometrial cells with Ki-S3 antibody. We also conducted immunohistochemical
studies of T-lymphocytes, B-lympho-cytes, macrophages, natural-killer-cells and also
of antigens class II of the histocompatibility complex (HLA-DR) during the different
phases of the menstrual cycle in endometriosis and non-endometriosis patients.
Endometrial lymphocyte subsets show equal quantity and distribution in endome-
triosis patients and in the control group. After a peak in the early preoliferative phase
the absolute number of T-lymphocytes decreases while a predominance of
T-suppressor/cytotoxic T-lymphocytes (CD8) compared to T-helper/inducer lympho-
cytes (CD4) occurs towards the end of the menstrual cycle.
It can be concluded that endometrium as the potential parent epithelia of endome-
triotic lesions seems not to be altered in its lymphatic cell content compared to healthy
women. Furthermore endometrium is clearly characterised as part of the mucosa
associated lymphatic tissue (MALT). T-lymphocytes show specific quantitative
changes due to different phases of the menstrual cycle.
Keywords: Immunohistochemical profile of endometrium, genital endometriosis, lymphocyte
subsets
INTRODUCTION
Endometriosis is a disease that primarily affects
women within the reproductive age. Many efforts
have been made to explain its pathogenesis as
metastatic, metaplastic or on the basis of some
immunological mechanisms. Retrograde men-
struation is accepted as a source of endometrial
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cells found in the peritoneal cavity [8]. This is
recognized as a common phenomenon but it is
still not known why only a small cohort of
women with patent Falloppian tubes suffer from
endometriosis. Numerous approaches have been
made in an effort to answer this question. During
the last years many investigators demonstrated
the association of endometriosis and changes in
the immune system which were elucidated as
alterations in cell-mediated as well as humoral
immunity [5,20].
The results suggest that the immune system
might play a substantial role in the pathogenesis
ofendometriosis and associated infertility. At the
same time the role of the immune system in the
pathogenesis of endometriosis and infertility re-
mains unclear.
We have undertaken this study in order to
elucidate whether or not there is any difference
between the proliferative activity of endometrial
cells in women with endometriosis and without it
and to see weather or not there is a difference in
occurence and distribution ofimmunocompetent
cells in the endometrium. To answer this ques-
tion we investigated the proliferative activity
of endometrial cells with Ki-S3 antibody. We
conducted immunohistochemical studies of
T-lymphocytes, B-lymphocytes, macrophages,
natural-killer-cells and also of antigens class II
of the histocompatibility complex (HLA-DR)
during the different phases of the menstrual
cycle.
The main group consisted of 143 patients with
endometriosis stages I-III (Fig. 1-3) (according
to the revised AFS classification [Americal Ferti-
lity Society 1985]) proved by direct laparoscopic
classification and partially by biopsy of lesions.
The patency of tubes were proved laparoscopi-
cally in all the patients. The mean age of the
patients of the group was 29.8 years (from 24 to
36), and the mean infertility period was 6.8 years
(from 3 to 14 years).
The control group included 110 patients with
laparoscopically proven tubal factor infertility
resulting from the prior pelvic inflammatory dis-
ease (PID). All patients had previously under-
gone antibiotic therapy. Although the tubes were
blocked partially in all the cases, there were no
signs of inflammatory process in progress at the
moment of laparoscopic investigation. Fimbrio-
plasties and salpingostomies (Fig. 4-6) were
performed frequently. The mean age of the
patients in the control group was 29.6 years
(from 24 to 35 years), the mean infertility period
--6.3 years (from 2 to 14 years).
Operative laparoscopy- pelviscopy and chro-
mopertubation 14] was performed in all patients
of both groups. The distribution over the men-
strual cycle revealed an incidence up to 7
patients per day. Within the framework of this
infertility protocol endometrial biopsies were
MATERIALAND METHODS
Endometrial specimen were obtained by biopsy
from 253 patients with regular (28-29 days)
ovulatory menstrual cycles (proved by basal body
temperature curves and blood progesterone
levels). All women underwent laparoscopy and
endometrial tissue biopsy with the framework of
infertility work up. No one had received any
medical treatment during the previous three
months.
FIGURE Pelviscopic site of endometriotic lesion on the
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FIGURE 2 Pelviscopic site of endometriotic lesions on the
surface of the ovary (AFS II).
FIGURE 4 Pelviscopic site of endosalpinpitis nodosa.
FIGURE 3 Ovarian endometriotic cyst (AFS III) at pelvi-
scopy.
FIGURE 6 Suturing of fimbria with intracorporal knotting
technique pelviscopic site.
FIGURE 5 Terminal salpingostomy and eversion of fimbria by pelviscopy.130 L. METTLER et al.
taken from all patients at the end of the laparo-
scopical interven tion after accomplishment of
all relevant endoscopical procedures. The tissue
samples were placed into liquid nitrogen and
kept till further processing at 80C.
The cycle day of each endometrial sample was
estimated taking into account the first day of the
last menstruation and by histological dating
according to DALLENBACH-HELLWEG [4].
In order to detect cellular proliferation we used
the proliferation specific antibody Ki-S3 which
recognizes a new epitope on the KI-67 nuclear
antigen [17]. The Ki-S3 antibody shows no core-
activity with non proliferation related structures
especially no coreaction with cytoplasm. The
appropriate number of cryostate sections 5
thick (Equipment: Frigo-Cut Mod 2700, Fa.
Reichert-Jung, Nussloch) were prepared for
immunochemical investigation with Ki-S3 anti-
bodies. Serial cryostat sections were mounted on
clean glass slides and air dried for 2 hours at
room temperature. Then sections were fixed for 5
minutes in acetone, dried and stored at -80C
till further processing.
The indirect immunoperoxidase technique
modified by STEIN et al. [6] allowed to obtain
brown-coloured reaction products in the area of
antigen bindings. The primary antibodies used
with their antigen determinant, cluster designa-
tion, related dilution, and sources are shown in
Table I.
For staining the slides were incubated with the
diluted primary antibodies at room temperature
for 30 minutes in 1% Ringeralbumin solution
(Bovines serum albumin in 0.05 M Tris/NaGl
solution pH 7.4).
For the following two colour steps the slides
were incubated for half an hour with the second-
ary and respectively third antibodies which had
to be diluted in 10% human albumin solution
from 1:15 to 1:150 (pH 7.4).
Peroxidase-conjugated rabbit-anti-mouse im-
munoglobulin (Dakopatts/Denmark) was used
as the secondary antibodies, and peroxidase-
conjugated goat-anti-rabbit immunoglobulin
(Danova, Hamburg) was used as the third anti-
bodies.
All slides were thoroughly washed several
times between these two particular colour steps
with 0.05 Tris/NaC1 solution (pH 7.4). The
peroxidase-developing reaction was observed
from 5 to 10 minutes with 3’, 3’ diamino-
benzidin-tetrachloride (0.6 mg/ml; Fa. Walter,
Kiel) and H202 (0.01 Vol %) in Tris/HCl-bufferat
pff 7.6. For the light microscopic investigation
the slides were counterstained with haemalaun
and stocked up with glycerin-gelatine (Fa. Merck,
Darmstadt).
The cryostat slides of human tonsils were used
to a certain optimal antibody dilution and for
positive control. For negative control the pri-
mary antibody was replaced by PBS-buffer.
Light Microscopy of Endometrium for
Quantitation of Lymphocytes
The analysis and evaluation was performed with
the light microscope (SM Lux, Leitz Company,
Wetzlar using an Ocular of x 25 and Objective of
40). The ocular of microscope contained
square rasters designed to keep regarding at a
magnification during the determination of the
absolute number of marked cells.
The fields were evaluated for each slide Corre-
sponding to the magnification 250 one real
field was 1.85 mm-, and to the magnification
400-0.76 mm-. For each of the slides the
absolute quantity of the cells marked by respec-
tive antibodies were calculated.
Statistical analysis of the results was made by
Student’s T-test. The conventional level of 0.05
was taken as a limit of significance. For diagram
representation the proliferation activity of epi-
thelial cells was presented as percent of Ki-S3
positive cells per 1000 epithelial cells while the
activity of stromal cells was considered as abso-
lute number of antibody-positive clls per one
square millimeter.IMMUNO HISTOCHEMICAL PROFILE OF ENDOMETRIUM IN PATIENTS 131
TABLE Applied monoclonal antibodies for immunohistochemistry
Name of
monoclonal
antibody
Cluster-
designation
(CD)*
Specificity of Occurrence of Dilution Source of
epitop antigen antibody
Anti-LEU-4
Anti-Lcu-3a
Anti-Lcu-2a
Anti-Lcu-7,
(HNK-I)
Anti-Human-B-
Cell,
Clone To 15
Anti-Human-
HLA-D,
Clone CR3/43
Ki-M 1P
CD 3
CD 4
CD 8
CD 22
molecular
weight (MW)
22-28 kD,
surface antigen
MW 55 kD,
surface-antigen
1. MW 32 kD
2. MW 43 kD
surface-antigen
MW 110 kD
MW 130 kD
MW 28 kD
beta-chain of
genc products of
HLA-DP, DQ
and -DR**
MW 60 kD
T-lymphocytes, 1:200
pan-T-marker
T4
helper/inducer-
lymphocytes;
[monocytes;
macrophages]
T8-cytotoxic/
suppressor-
lymphocytes
Natural Killer
cells (NK);
B-lymphocytes,
pan-B-marker
B-lymphocytes,
macrophages,
activated T-
lymphocytes
dendritic cells
1:400
1:400
1:50
1:100
1:500
Becton-
Dickinson, USA;
No. 7340
Becton-
Dickinson, USA;
No. 6320
Becton.-
Dickinson, USA;
No. 6310
Becton
Dickinson, USA,
No. 7390
Dakopatts,
Denmark
No. M708
Dakopatts,
Denmark,
No. M775
histiocytes, 1:5.000-10.000 Inst. of Pathol.,
blood monocytes Kicl, Germany
Ki-M 6 CD 68 MW 60 kD; histiocytes, 1:5.000 Institute of
intracytoplasmat blood monocytes Pathology
antigen; surface Kicl, Germany
membrane of
phagosomcs and
lysosomcs
Ki-M 8 1. MW 30 kD histiocytcs, 1:5000
2. MW 32 kD; blood monocytcs
intracytoplasmat
antigen surface
membrane of
phagosomcs and
lysosomes
Ki-S 3, 1. MW 340 kD proliferating 1:8.000
2.MW390 kD; cells in
nuclear Antigen cell cycle-phases
GI, S, G2, M
Institute of
Pathology
Kiel, Germany
Institute of
Pathology
Kiel, Germany
*III. International Workshop on Human Leukocyte Differentiation Antigens, Oxford 1986.
**International Workshop on Monoclonal Antibodies to Human MHC Class II Antigen, 1983.132 L. METTLER el al.
RESULTS
General Data
There were no endometrial structural abnormal-
ities.
Proliferative Activity ofSuperficial Epithelial
Cells
At the early proliferation phase of the control
group the Ki-S3 positive of superficial epithelial
cells was as high as 36%. Then it slightly in-
creased to 38% on day 10 of the menstrual cycle
and afterwards it slowly decreased to Zero on
day 26 of the cycle. After day 26th no Ki-S3
positive cells were found in superficial epithelia.
In the endometriosis group 40% of superficial
epithelial cells of endometrium were found as
Ki-S3-positive in the early follicular phase and
the other phases followed the pattern of the
control group.
The dynamics of Ki-S3 positivity during the
entire menstrual cycle are seen in Fig. 7A.
The slight differences were found as statisti-
cally not significant and variable at all the points
(p > 0.05).
Proliferative Activity ofGlandular Epithelium
In the control group the percentage of Ki-S3
positive cells ascended dramatically from 7% on
day 5 of the cycle to 57% on day 10 of menstrual
cycle. The level of glandular cells positivity was
as high (with a slight decreasing to 30% on day 12
of the cycle) till the 15th day and afterwards the
proliferative activity decreased quite rapidly to
the 24th day of menstrual cycle.
After the 25th day of the cycle no more prolif-
erative activity of glandular cells was found
according to Ki-S3 positivity.
The Ki-S3 positivity in the endometriosis
group demonstrated the same pattern.
Comparing the percentage of proliferative ac-
tivity during menstrual cycle in the glandular
epithelium in both groups no statistical differ-
ence (P > 0.05) could be detected. The course of
Ki-S3 positivity in both control and endometrio-
sis groups was very similar (Fig. 7B).
Proliferative Activity ofStromal Cells
In the control group the number of Ki-S3 anti-
body marked cells demonstrated a rapid increase
from 200 cells per mm- on day 5 of the men-
strual cycle up to 500 cells per mm-
on day 10 of
the cycle. After a slight decrease between day 11
and 13 a second elevation of proliferative activ-
ity of stromal cells reaches in average 700 Ki-S3
positive cells per mm-
of the stroma on day 16
of the cycle and a mean number of 430 activated
cells per mm-
on day 17 of the cycle. From that
day the quantity of Ki-S3 positive cells fluctuates
around 400 active cells per mm- up to the end
of menstrual cycle.
The same course with a negligible difference
(P > 0.05) was found in respect of Ki-S3 positiv-
ity of stromal cells in the endometriois group at
all points of the entire menstrual cycle (Fig. 7C).
The above described features of proliferative
activity of superficial epithelial cells, glandular
epithelial cells and stromal cells in the control
group and in the endoometriosis group are pre-
sented in Fig. 8 demonstrating immunohis-
tochemically treated tissue samples.
T-Lymphocytes
Anti Leu 4 (CD3) Pan T-Lytnphoctes
(Figure 9,4)
In the control group the number ofCD3 positive
lymphocytes at the early proliferation phase
started from values of 420 cells per mm- on day
5 of the menstrual cycle to 570 CD3 positive
cells per mm
2 on day 6 of the cycle (P > 0.05).
After the 6th day of the cycle the number of
CD3 positive cells decreased continuously to a
mean value of 180 cells per mm-
on day 12.
Further on the CD3 positive cells remained
relatively constant varying between 100-150IMMUNO HISTOCHEMICAL PROFILE OF ENDOMETRIUM IN PATIENTS 133
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FIGURE 7 Proliferating endometrial surface epithelia (A), glandular epithelia (B) and stromal cells (C) in women with
endometriosis compared to a control group throughout the menstrual cycle. [sd: standard deviation]134 L. METTLER et al.
FIGURE 8 Ki-S3 as a marker of endometrial proliferation. In early follicular phase (A, x 350) few glandular epithelia (broad
arrow) and single stromal cells (small arrows) showing proliferative activity. Note lymphocyte aggregation (open arrows)
containing some proliferating cells. Maximum occurrence of Ki-S3 positive stromal cells (arrows) at time of ovulation (B,
x 350). Complete arrest of proliferation in glandular epithelial in contrast to increasing numbers of Ki-S3 positive cells (arrows)
in endometrial stroma on cycle day 23 (C, x 700). Lymphocyte aggregation in late secretory phase (D, x 700) demonstrating
numerous proliferating cells.
cells per mm
2 till the end of the cycle. The
comparison of the mean level and dynamic
pattern of CD3 positive lymphocytes in endo-
metrium during menstrual cycle demonstrated
no significant differences in women with endom-
etriosis compared to the control group almost on
all days of the cycle (P > 0.05). Figure 10 dem-
onstrates T-lymphocytes scattered in the endo-
metrium around ovulation.
,4nti-Leu 3a (CD4):Helper
T-Lymphocytes Figure 9B
In the control group the number ofCD4 positive
lymphocytes had the maximal value on days 5
and 6 of the menstrual cycle corresponding to
10-120 CD4 positive cells permm2 and rapidly
decreased till the end of follicular phase to 30
T-lymphocytes per mm-
on day 13 of the cycle.
After an insignificant increase on day 16 it
slightly decreased to the mean level of 20 CD4
positive cells per mm
2 (P > 0.05) up until the
end of menstrual cycle.
In patients with endometriosis during the en-
tire menstrual cycle the dynamic pattern ofCD4
positive lymphocytes corresponded exactly to the
course of the control group without any signifi-
cant differences (P > 0.05).IMMUNO HISTOCHEMICAL PROFILE OF ENDOMETRIUM IN PATIENTS 135
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FIGURE 9 Different subsets of T-lymphocytes ,in the endometrium of women with endometriosis compared to a control
group. [sd: standard deviation]136 L. METTLER et al.
registered as 20 cells per mm
2 on day 5 of
menstrual cycle. In endometriosis patients the
number of Leu 7 positive lymphocytes was con-
stant during the entire menstrual cycle with neg-
ligable variations of the mean number from 0.6
to 4 Leu 7 positive cells per mm2. The course of
cells did not statistically differ from the controls
(P > 0.05).
FIGURE 10 Scattered endometrial CD3 positive T-lymp-
hocytes (arrows) in follicular phase x 350).
Anti-Leu 2a (CD8): Suppressor/Cytotoxic
T-Lymphocytes Figure 9C
The maximal level of CD8 positive lymphocytes
in the control group was found on days 5-8 of
the menstrual cycle with 125 CD8 positive cells
per mm2 From day 9 of the cycle the number
dramatically decreased to mean values of 48 cells
per mm
2 on day 14 of the menstrual cycle.
Duringthe luteal phase of the cycle after day 14
the mean number of CD8 positive cells was
relatively constant slightly but not significantly
increasing towards the end of the cycle
(P > 0.05).
In patients with endometriosis variations of
CD8 positive lymphocytes quantity per mm2
corresponded to the levels of those in the control
group during the entire menstrual cycle. The
differences were not statistically significant
(P > 0.05).
Natural Killer Cells: Anti-Leu 7
Throughout the entire menstrual cycle Leu 7
positive cells were noted as very scanty, weak
coloured without special localization. These cells
were found in endometrial stroma and in lym-
phocytes aggregations. Some slides demonstrated
no Leu 7 positive cells. The maximal number of
Leu 7 positive lymphocytes in the controls was
B-Lymphocytes
AntiHuman B-Lymphocytes Figure 11
They were almost exclusively detected in lym-
phocytes aggregations (Fig. 12). Similar micro-
scopic pictures were found both in the control
group and in patients with endometriosis.
The endometrium of endometriosis patients
contained the maximal quantity of CD-22 posi-
tive cells on days 5-8 of the menstrual cycle (40
cells per mm2). Then the number of CD-22 pos-
itive cells decreased to the end of proliferation
phase to 20 cells per mm
2 on day 11 of the cycle
and afterwards the mean values varied from 10
to 25 CD-22 positive cells with peak values of
20-21 cells on day 13.
No differences occured in the 2 investigated
groups.
Anti HLA-DR
HLA-DR Expression in the Endometrial Stroma
HLA-DR positive cells were found in different
layers of endometrium in patients of both
groups: there was no real difference between the
endometriosis group and the controls. In both
groups the endometrial samples of basal stroma
and lower basal layer contained HLA-DR posi-
tive cells with much density as compared to
superficial endometrium (Fig. 13A).
HLA-DR was particularly pronounced at the
late secretory phase. Endometrial stroma and
lymphocytes aggregations consisted almost exclu
sively of positive cells. The single HLA-DR pos-IMMUNO HISTOCHEMICAL PROFILE OF ENDOMETRIUM IN PATIENTS 137
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FIGURE 11 CD22 positive B-lymphocytes in the endometrium of women with and without endometriosis. [sd: standard
deviation]
increase of the number of positive cells to the
mean value of 300 cells per mm2. There were no
significant difference pattern discernable.
FIGURE 12 Lymphocyte aggregation consisting almost ex-
clusively of B-lymphocytes 700).
itive cells were found occasionally in intraepithe-
lial and subepithelial layers of endometrium
which were distinguished from the epithelum.
Quantitative features of HLA-DR positive cells
were similar in both groups of patients.
Beginning with the 5th day of menstrual cycle
the number of HLA-DR positive cells decreased
in both investigated groups from the mean value
of 470 HLA-DR positive cells per mm2 to 200
cells per mm2 on day 12 of the cycle. After the
25th day of the menstrual cycle we noted a slight
HL4-DR Expression in Superficial Epithelium
No differences were found in distribution and
intensity of HLA-DR expression of superficial
epithelia in both the control and endometriosis
groups. HLA-DR positive superficial cells were
detected in the epithelial samples of both groups
during the entire menstrual cycle, however, their
amount decreased continuously after preovula-
tory maximum towards the end of the cycle
(Fig. 13B).
HLA-DR Expression in Glandular Epithelium
(Figure 13C)
No significant cyclic dependence was found in
the HLA-DR positivity of glandular epithelium
in both the endometriosis and control groups. In
the follicular phase of the cycle HLA-DR positiv-
ity of glandular epithelium was observed in more
than half of the slides. The majority of epithelial
cells demonstrated the equal low colour inten-138 L. METTLER et al.
E o
0
1000
800
600
400
200
endometriosis, n=140
control, n=108
mean +/- sd
A
7 9 11 13 15 17 19 21 23 25 27 29
day ol menstrual cycle
(R) 0,8 O
(R) 0,6
O
$ 0,4
’- 0,:2
5 7 9 11 13 15
endometriosis, n=140 B
control, n=108
."2]
day of menstrual cycle
11 13 15 17
endometriosis, n=140
control, n=108
19 21 23 25 27
day of menstrual cycle
C
FIGURE 13 HLA-DR positive stromal cells (A) in the endometrium of women with endometriosis. Occurrence of HLA-DR
positive surface (B) and glandular (C) epithelia in endometrial biopsies ofwomen with endometriosis. [sd: standard deviation]IMMUNO HISTOCHEMICAL PROFILE OF ENDOMETRIUM IN PATIENTS 139
sity. After the 13th day of menstrual cycle the
number of the slide with HLA-DR positivity in
glandular epithelium dramatically decreased.
The antibody positive epithelial cells were inten-
sively coloured and restricted mainly to the lu-
men. Figure 14 shows the characteristic features
of HLA-DR positive cells in the endometrium.
Macrophages (Figure 15)
The occurrence and distribution of macrophages
in endometrium during the menstrual cycle were
approximately similar in both investigated
groups. The changes in cell-quantity studied with
the help of macrophages antibodies Ki-Mlp,
Ki-M6 and Ki-M8 were negligable (P > 0.05),
allowing to be described together. At the begin-
ning of the menstrual cycle the average number
of the observed macrophages varied between
150-200 cells per mm2 and slowly decreased to
100 +/- 10 cells per mm
2 on day 10-11 of the
menstrual cycle.
In glandular epithelium they were detected
mainly as subepithelial cells. In lymphocyte
aggregation macrophages were found mostly at
margins, they occured usually as scattered single
cells in lymphocyte aggregations (Fig. 16).
Lymphocyte Aggregations
Lymphocytes aggregations were observed during
the entire menstrual cycle in both groups of
FIGURE 14 Homogenous HLA-DR expression in glandular and surface epithelia in early proliferative phase (A, x 700).
Lymphocyte aggregations (arrows) showing intensive HLA-DR expression (B, x 350, cycle day 16). On cycle day 23 (C, x 700)
single surface epithelia and scattered cells in the stroma (arrows) labelling for HLA-DR. In late secretory phase (DE, x 175)
stromal HLA-DR expression contrasting to negative glands (arrows).140 L. METTLER et al.
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FIGURE 15 Ki-Mlp positive (A), Ki-M6 positive (B) and Ki-M8 positive (C) macrophages in the endometrium ofwomen with
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FIGURE 16 Macrophages scattered in endometrial stroma
(arrows) and at the margin of a lymphocyte follicle (open
arrows) in secretory phase x 700).
patients. In the control group these aggregations
were found in 22% of samples during the follicu-
lar phase and in 10% during luteal phase of the
cycle. In the endometriosis group the lympho-
cytes aggregations were revealed in 27% of the
slides during follicular phase and in 6% during
the luteal phase. There was no difference in
aggregation features in both of the investigated
groups. They consisted ofmany hundreds of cells
located mainly in the lower functional layer.
Small groups of lymphocytes were present
around the glands. Larger lymphocytes aggrega-
tions with a higher density of cells were addition-
ally detectable.
DISCUSSION
Proliferation Activity
The proliferation specific monoclonal antibody
Ki-S3 is able to allocate dividing cells in the
tissue without any crossreactivity to cytoplasmic
structures directed to the Ki-S7 antigen
(GERDES et al. 1984). The results with the
proliferation specific monoclonal antibody Ki-S3
clearly monitor the cycle derived changes in the
proliferation activity of the cellular components
of the endometrium. In addition it becomes
evident that considerable differences exist in the
proliferation behavior of various cell types dur-
ing the menstrual cycle. As expected the superfi-
cial and glandular epithelium proved to show
high proliferation activity starting from the 5th
day of menstrual cycle and keeps this level of
activity up to ovulation without a recognizable
maximum. After the 23th-25th days of the
menstrual cycle the superficial and glandular
epithelium demonstrated no more proliferative
activity.
According to DALLENBACH-HELLWIG [4]
the mitosis and DNS level, as demonstrated by
light microscopy, reaches the maximum in epi-
thelium and stroma at the time of ovulation.
Then the dividing activity decreases and after
day 18-19 of the cycle in glandular epithelium
and to the 20th-21th days in stromal cells it
demonstrates no mitotic activity at all. In the
luteal phase there is an increase of mitotic
division.
Due to the fact that Ki-S3 monoclonal anti-
bodies not only allow to allocate the proliferating
cells which appear in the relatively short mitotic
phase (M) of the cell cycle but also to recognize
the cells of the premitotic (G2 postmitotic (G 1)
phase and the DNA-synthesis phase (S), we
consider our results to be supportive of
DALLENBACH-HELLWEG’s [4] data.
The described results of the study concerning
distribution and pattern of proliferative cell ac-
tivity in patients with endometriosis and in
control-patients include data of immunohis-
tochemical studies of endometrium in healthy
women [16,23]. The immunohistochemical stud-
ies of occurence and distribution of steroid re-
ceptors in the female genital tract [19] demon-
strate the coherence of estrogen receptors (ER) as
well as growth and differentiation of endom-
etrium. Using semiquantitative immunohis-
tochemical methods PRESS et al. 19] report that
distribution and intensivity of certain concentra-
tions ofER in endometrium reflects the prolifer-
ation features of this tissue.142 L. METTLER et al.
The maximal ER content in all layers of en-
dometrium was found at the moment of ovula-
tion which corresponded to a high proliferative
activity of stromal cells reflecting the activity of
functional and basal layers. At the secretory
phase the ER content declined. These findings
correlate with mitotic rest of glandular epithe-
lium but not with the status of numerous avail-
able actively dividing cells in the stroma. The
described difference can be attributed to the
cycle dependent receptors and to epidermal
growth factors (EGF) whichappear to be active
mitogens.
Some authors report of a marked elevated
quantity of EGF-receptors at the follicular phase
of the cycle with its maximum in the preovula-
tory moment. Other investigators [18] describe
in their immunohistochemical study of EGF-
receptors in the endometrium of healthy women
and in patients with endometriosis the uniform
expression of these receptors without any cycle
dependent alterations.
The immunohistochemical study of leucocytes
(CD45, CD 11 c, Cb3) with monoclonal antibody
Ki-67 demonstrated the existence of actively di-
viding lymphocytes in lymphocytes aggregations
and as individual cells in the endometrial stroma
16,21 ]. The number of these cells increased dra-
matically during the luteal phase of the cycle.
Thus, the proliferative activity of endometrial
stromal cells at the end of menstrual cycle co-
exists with an increase of dividing activity of
immunocompetent cells and is partially attrib-
uted to the occurence of these cells.
T-Lymphocytes
Different T-lymphocytes subgroups existing at
variable numbers during the entire menstrual
cycle were revealed as single cells as well as
intraepithelial or subepithelial cells in aggrega-
tions. The dynamic patterns of cell numbers
were nearly identical during the menstrual cycle
in both the control and endometriosis groups.
The highest cell quantity was demonstrated by
the pan-lymphocytes-marker anti-Leu4 (CD3).
The features the subgroups demonstrated were
two maximas in the early proliferation phase
and at the end of the secretory phase with
almost a horizontal curve in between. The most
striking changes of cell numbers were found at
the early and mid proliferation phases. The
quantity of different T-lymphocytes expressed
the slight fluctuations during the second half of
the cycle which did not exceed +/- 1- cells per
mma The relatively high cell number at the
beginning of menstrual cycle may be explained
anatomically. The functional layer of endom-
etrium has a thickness from 0.5 to 4 mm. Thus
at the beginning of the proliferation phase a
biopsy of the deepest part of endometrium with
a high cell density may be taken. It also may be
valid for a more frequent occurence of lympho-
cyte aggregations in the proliferative phase as
compared to the secretory phase. CD4 positive
and CD8 positive cells during the early prolifer-
ation phase revealed almost an equal quantity,
and the ratio of CD4 to CD8 was almost 1:1.
After the common decrease of cells numbers in
the proliferative phase the number of CD4 pos-
itive cells continuously decreased while the level
ofCD8 positive cells was relatively constant. We
could observe a predominance of CD8 positive
T-lymphocytes with the ratio of CD4 CD8
between 1:2 and 1:4. This predominance of
CD8 positive suppressor lymphocytes in com-
parison with CD4 positive T-helpers was found
in both groups of the patients. These data corre-
spond to the ones of VIGANO et al. [24] con-
cerning women with endometriosis. The study
of T-lymphocytes in the thoracic duct of men
and women [3] demonstrated that only CD8
positive lymphocytes, but not CD4 positive ones
possessed estrogen receptors. Evidently, there is
the preference of these cells in estrogen sensitive
tissues. MORRIS et al. [15] declared the ratio of
intraepithelial CD4 positive T-lymphocytes and
CD8 positive T-lymphocytes occurence as high
as 1:4. These data correspond to the results of
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same ratio for women with endometriosis. It is
difficult to conclude if the noted increased ratio
was due to the presence of endometriosis or only
infertility. We may explain it by the fact that
most T-lymphocytes in the endometrium act
as TCR-l-lymphocytes which make up only 5%
of all T-lymphocytes but are found mainly in
skin and mucosa. They are CD3 positive and
can express CD8-epitopes but not CD4 epitopes
[3,12].
The quantity of Leu-7 positive cells in the
patients with endometriosis and in the controls
were practically undistinguishable. LYDYARD
and GROSSI in their study of immunological
properties ofnatural killer cells (NK cells) proved
the presence of small numbers of Leu-7 positive
NK cells in endometrium which were the subject
to discrete cyclic fluctuations. The analogous re-
sults concerning the endometrium of healthy
women were described by KAMAT and ISAAC-
SON 1987, KING et al. 1988 [9,10].
Immunohistochemical double colouring pro-
ves that proliferation activity inendometrial
stroma at the end of menstrual cycle is not only
attributed to stromal cells but also to leucocytes
[23]. Proliferating activity of granulocytes also
exists in proliferating T-lymphocytes. Immuno-
histochemical double colouring for proliferation
specific antibodies and other NK-cell-markers
may give us additional information whether the
endometrium of endometriosis patients and in-
fertile patients gives different results in respect to
proliferation activity of granulocytes.
B-Lymphocytes
Only few single B-lymphocytes were found in the
endometrium of investigated patients. Their
number increased considerably in some lympho-
cyte aggregations forming areas within these
aggregations almost exclusively consisting of
B-lymphocytes. Our findings coincide with im-
munochemical investigations of endometrium in
healthy women 15,9,11 ].
Anti HL-DR
The investigation ofHLA-DR revealed no differ-
ence in expression of this antigen during the
menstrual cycle in different layers of endo-
metrium in patients of both groups.
LAGUENS et al. [11] described in their study
the cyclic dependent increase of HLA-DR posi-
tive cells in endometrial stroma from 13-25% in
the proliferation phase to 16-43% at the late
secretion phase. The macrophages HLA-DR pos-
itivity input was estimated as 1/10 to 1/2 of
HLA-DR positive cells. No HLA-DR positive
cells and macrophages were found in the endom-
etrium of post-menopausal women. Therefore
HLA-DR positive cells may be the subject to
direct or indirect hormonal influence.
The results of other investigations demon-
strated no increase of HLA-DR positive stromal
cells during the menstrual cycle [22]. A possible
explanation of the discrepancy of results in the
present study and the others mentioned may be
the small number of investigations and matched
ages of patients in those investigations.
In tissue culture slide [22] it was noted that the
addition of either T-lymphocytes or- interferon
to human endometrium culture may have a dose
dependent influence on HLA-DR expression and
proliferation activity of endometrial cells. The
authors consider this T-cells mediated effect as
possible explanation for the reinforced prolifera-
tion of functional endometrium. One of the
important points of these observations is the
possibility of local influence on the hormone
dependent tissue by cells of the immune system.
It is also possible to assume the interaction of the
immune system due to the existence ofHLA-DR
antigens in the endometrial stromal and epithe-
lial cells.
Macrophages
Macrophages in endometrium were mainly
homogenously distributed in the endometrial
stroma. Occasionally they were found in intra-144 L. METTLER et al.
and subepithelium. The importance of macro-
phages in the endometrium in connection with
endometriosis and associated infertility remains
unclear. At the same time some investigators
report of an increased level of macrophages and
macrophage activity in the peritoneal fluid of
patients with endometriosis [7,8,13]. Certainly
we 13] described this fact in earlier studies and
are still investigating on MCSF the macrophage
stimulation factor activity in ectopic endo-
metrium.
We failed to find any study in the literature
concerning the occurence of macrophages in the
endometrium of women with endometriosis. As
far as women without endometriosis are con-
cerned some authors report on the occurence
of macrophages during the menstrual cycle 10].
Others found either an elevated number of
macrophages at the secretory phase [11] or an
increased dividing activity during the secretory
phase [21,24].
Follicle Like Lymphocyte Aggregations
The aggregations were mainly located in the
lower functional and basal layers of endom-
etrium consisting of B-lmyphocytes in the central
area, and of T- lymphocytes which were mostly
represented in the margin areas. Almost all aggre-
gations of lymphocytes expressed HLA-DR posi-
tivity. The dividing activity was marked during
the entire menstrual cycle. Similar data concern-
ing the occurence, distribution and composition
of lymphocytes aggregations in the endometrium
ofwomen with endometriosis are reported which
are based on the results of small groups of
patients without matched age [21,15,9].
In conclusion, our study based on the compar-
ison of some functions of endometrial cells of
infertile women with endometriosis and without
endometriosis demonstrates the high level of
proliferative activity of stromal cells at the end of
menstrual cycle. These data is confirmed by the
vitality and potential ability of endometrial cells
to survive in the peritoneal cavity.
Answering the question if the proliferative
activity of endometrial cells varies in women
with and without endometriosis we can clearly
state that there is no difference in endometriosis
and non endometriosis patients.
The lack of any difference in proliferative
activity in the control and endometriosis groups
might be an evidence that the cause for deriving
endometriosis from endometrial cells probably
should be attributed to the responsibility of the
extrauterine milieu.
The observed quantitative differences in
occurence, distribution, number and correlation
among different subpopulations of T- and B-
lymphocytes macrophages, lymphocytes aggrega-
tions and the expression of HLA-DR positivity
demonstrated in both groups quite clearly a cy-
clic dependence. It provides us with evidence of
a tight connection between ovarian function and
local functions of immunocompetent cells and
confirms the characteristics of endometrium as
mucosa associated lymphatic tissue.
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